SIRT6 is overexpressed in CD34+ hematopoietic progenitors and multiple myeloma in patients with acute myeloid leukemia, and high SIRT6 levels are associated with poor prognosis (131, 132). This evidence concerns the gene SIRT6 and acute myeloid leukemia.